Navigation Links
Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients

In a research co headed by Jill Buyon, M.D., of New York’s Hospital for Joint Diseases said that oral contraceptives can be given to women with inactive or stable Systemic// Lupus Erythematosus (SLE) and they would not show symptoms of increased risk of flares of the disease.

This research was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). In this disease the body fails to recognize as self and starts to attack its own tissues of the skin, joints and other internal organs.

Initially clinicians are very hesitant to give contraceptive pills (orally) to the patients with SLE because of the fear that they might show increased and unwanted disease activity.

This study which included 183 women with inactive or stable SLE were given oral contraceptives (triphasic 35 μg.ethinylestradiol/0.5-1 mg norethindrone for twelve 28-day cycles).they did not show any difference in reaction when compared to the controls who were given placebo.

Seven percent of the women showed severe reaction in both the test as well as in control categories. They suffered from various symptoms like new or worsening central nervous system involvement; inflammation of the blood vessels (vasculitis), kidneys (nephritis) and/or muscles (myositis); and/or blood problems, low platelet count (thrombocytopenia) and complete destruction of the red blood cells (hemolytic anemia).

Moderate reactions were seen in both the categories over the one year follow up session which includes fevers, inflammation of the skin, joints, pericarditis, and mucous membranes lining the nose and mouth.

This disease is very common among women. The ratio of women to men suffering from this disease is 10:1. Women usually suffer during the child bearing age when the female hormones are at its peak.

When experiments were conducted with mouse with SLE they showed increased reaction when administered with estrogen. They also affected the B cells which plays a vital role in the disease process.

According to this study it is clearly seen that women suffering with inactive or stable SLE can take estrogen without any fear of increased reaction due to the disease. But on the other hand women suffering from a risk of blood clots are not supposed to take oral contraceptives as estrogen increases blood clot formation.

Hence in conclusion this study has improved the quality of the life of people with rheumatic disease
'"/>




Related medicine news :

1. Usage of coil better in brain haemorrhage
2. Oxygen Usage During Exercise Could Indicate Heart Problems
3. The Usage Of Anti-Inflammatory Drugs Questioned
4. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Dummy Usage Raises Doubts.
8. More The Usage More The Growth In The Adult Brain.
9. Ignorance in the Usage of Pill Persists Among Many Women
10. Vaticans Council Reviews Condom Usage
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017   Divoti USA ... Jewelry up to the standard of the latest FDA requirements, which ... 2017). Anyone in need of Medical ID jewelry such ... Alert Jewelry are engraved in terms of the new ... Divoti offers ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
Breaking Medicine Technology: